✦ LIBER ✦

390 POSTER A Phase I dose-escalation study of XL228, a potent IGF1R / Src inhibitor, in patients with advanced malignancies

✍ Scribed by C. Britten; D.C. Smith; L.A. Bui; D.O. Clary; H.I. Hurwitz

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

342 POSTER A phase I dose-escalation and

✍ B.I. Sikic; H.A. Wakelee; A.A. Adjei; J. Halsey; J.L. Lensing; J.D. Dugay; L.J. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 68 KB

405 POSTER A phase I dose-escalation stu

✍ R. Kurzrock; L. Camacho; D. Hong; C. Ng; L. Janisch; M.J. Ratain; R. Salgia 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 90 KB

427 POSTER Pharmacokinetics (PK) of EZN-

✍ A. Patnaik; M. Goldston; C. Takimoto; A. Tolcher; K. Papadopoulos; T. Bekaii-Saa 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 87 KB

395 POSTER Phase I study of XL844, a nov

✍ A. Tse; S. Yazji; A. Naing; D. Matthews; G. Schwartz; K. Lawhorn; R. Kurzrock 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Sunitinib combined with pemetrexed and c

✍ Blais, Normand; Camidge, D. Ross; Jonker, Derek J.; Soulières, Denis; Laurie, Sc 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 253 KB

A phase I study of escalating doses of d

✍ Masters, G.A; Brockstein, B.E; Bertucci, D; Mani, S; Ratain, M.J 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 224 KB